(19)
(11) EP 4 404 943 A1

(12)

(43) Date of publication:
31.07.2024 Bulletin 2024/31

(21) Application number: 22786458.4

(22) Date of filing: 22.09.2022
(51) International Patent Classification (IPC): 
A61K 31/728(2006.01)
A61M 1/00(2006.01)
A61M 11/00(2006.01)
A61M 31/00(2006.01)
A61P 15/02(2006.01)
A61K 33/00(2006.01)
A61M 3/00(2006.01)
A61M 25/00(2006.01)
A61M 35/00(2006.01)
A61P 31/10(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/728; A61K 33/00; A61M 31/00; A61P 15/02; A61P 31/10; A61M 35/30; A61M 3/0233; A61M 3/0245; A61M 2210/1483; A61M 2210/1475; A61M 11/02; A61M 2202/0208; A61M 2209/06; A61M 2205/3334; A61M 11/06; A61M 2202/0468
 
C-Sets:
  1. A61K 31/728, A61K 2300/00;
  2. A61K 33/00, A61K 2300/00;
  3. A61M 2202/0208, A61M 2202/0007;

(86) International application number:
PCT/IB2022/058964
(87) International publication number:
WO 2023/047326 (30.03.2023 Gazette 2023/13)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 24.09.2021 IT 202100024544

(71) Applicant: Montanari, Federico
40050 Argelato (BO) (IT)

(72) Inventor:
  • Montanari, Federico
    40050 Argelato (BO) (IT)

(74) Representative: Perani & Partners S.p.A. 
Piazza Armando Diaz, 7
20123 Milano
20123 Milano (IT)

   


(54) ASSOCIATION OF MOLECULAR OXYGEN AND HYALURONIC ACID OR SALTS THEREOF FOR USE IN THE TREATMENT OF CANDIDIASIS